23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
Provided By GlobeNewswire
Last update: Nov 12, 2024
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, reported its financial results for the second quarter of fiscal year 2025 (FY25), which ended September 30, 2024.
Read more at globenewswire.com
